Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil for HBV in HIV Co-infected Patients with Decompensated Liver Disease
NCT00013702Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adefovir dipivoxil in hepatitis B (HBV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2001; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00013702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00013702.